Dendritic Cells-Derived Exosomes in Human Sepsis

• Status: Unknown status
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The amount of peripheral blood exosomes has been confirmed to change in the endotoxin-induced infection. The primary objectives of this study are to compare the changes of peripheral blood dendritic cell-derived exosomes in the patients with sepsis and the healthy controls.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jinling Hospital, China
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular

Criteria

Inclusion Criteria:

• Patients were selected with the diagnostic standard "Sepsis 3.0".

• Healthy volunteers do not have serious illness.

Exclusion Criteria:

• Patients or volunteers do not agree to provide written informed consent and / or can not be legally authorized to provide informed consent.

• Patients give up treatments.

• Patients or volunteers withdrew from the study.